# Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris

> **NCT03662685** · PHASE1 · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 4 (actual)

## Conditions studied

- Psoriasis Vulgaris
- Psoriasis

## Interventions

- **OTHER:** Goeckerman Therapy
- **DRUG:** Crude Coal Tar Only
- **DEVICE:** Phototherapy Only

## Key facts

- **NCT ID:** NCT03662685
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-01
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-05-31
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Closing of the Goeckerman program at UCSF and loss of funding, PI left UCSF
- **Last updated:** 2025-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03662685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03662685, "Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03662685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*